The remaining 8 PGs, for which transcripts were expressed at a frequency of 84% (GPC1), 86% (GPC3), 88% (GPC4), 70% (GPC6), 100% (SDC1), 94% (SDC2), 93% (SDC3) and 95% (SDC4) of the tumour cases, respectively, were found to be differently modulated. This evidence concerns the gene GPC4 and neoplasm.